DeepCure announced today the appointment of Dr. Han Lim as Chief Business Officer (CBO). Dr. Lim will lead all business development, portfolio planning, and corporate strategy functions at the company.
DeepCure, a Boston-based A.I. drug discovery company, raised $40 million in Series A funding. Morningside Ventures led the round and was joined by investors includingTLV Partners, Sapir Venture Partners, and Benon Group
MIT Startup Exchange is pleased to announce the addition of six companies to its roster of STEX25 startups. New additions to the program include: Amogy, DeepCure, E25Bio, OPT Industries, Pathr, and Sync Computing.